A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy

Supportive Care in Cancer

Volumn 7, Issue 5, 1999, Pages 347-353

  Needles, Burton ^a   Miranda, Eduardo ^b   Garcia Rodriguez, Francisco M ^c   Diaz, Luis Baez ^d   Spector, Jesse ^e   Craig, Johnny ^f   Cohen, Gary ^g   Krasnow, Steven ^h   Brogden, Janice ⁱ   Ames, Michael ⁱ  

^a ST JOHN S MERCY MEDICAL CENTER   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

^c HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

^d VA MEDICAL CENTER   (Puerto Rico)

^e Berkshire Physicians and Surgeons   (United States)

^f CHRISTUS Schumpert St Mary Place   (United States)

^g GREATER BALTIMORE MEDICAL CENTER   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ GLAXOSMITHKLINE   (United States)

Author keywords

5 HT3; Nausea; Ondansetron; Oral antiemetic; Vomiting

Indexed keywords

BLEOMYCIN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; METHOTREXATE; MITOMYCIN; NAVELBINE; ONDANSETRON; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; NAUSEA; NEOPLASMS; ONDANSETRON; PUERTO RICO; TREATMENT OUTCOME; UNITED STATES; VOMITING;

EID: 0032812906     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050274     Document Type: Article

References (17)

1. Beck TM, Hesketh PJ, Madajewicz S, et al (1992) Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting. J Clin Oncol 10:1969-1975
2. Carmichael J, Bessel EM, Harris AL, Hutcheon AW, Dawes PJDK, Daniels S (1994) Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis in the cytotoxic-inducted emesis. Br J Cancer 70:1161-1164
3. Cubeddu LX (1992) Mechanisms by which cancer chemotherapeutic drugs induce emesis. Semin Oncol 19:2-13
4. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990) Efficacy of ondansetron (GR38032X) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322:810-816
5. D'Acquisto RW, Tyson LB, Gralla RH, et al The influence of a chronic high alcohol intake on chemotherapy-induced nausea and vomiting. Proc Am Soc Clin Oncol 5:257
6. 3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Support Care Cancer 6:237-243
7. Gralla RJ, Itri LM, Pisco SE, et al (1981) Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305:905-909
8. Gralla RJ, Navari RM, Hesketh PJ, et al (1998) Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy. J Clin Oncol 16:1568-1573
9. 3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting: a comparison of their pharmacology and clinical efficacy. Drug 55:173-189
10. Hesketh PJ, Kris MG, Grunberg SM, et al (1997) Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 15:103-109
11. Kris MG, Gralla RJ, Clark R et al (1985) Incidence, course, and severity of delayed nausea and vomiting following administration of high-dose cisplatin. J Clin Oncol 3:1379-1384
12. Krzakowski M, Graham E, Goedhals L, et al (1998) A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Anticancer Drugs 9:593-598
13. Lindley CM, Hirsch JD, O'Neill CV, et al (1992) Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1:331-340
14. Perez EA, Hesketh J, Sandbach J, et al (1998) Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study. J Clin Oncol 16:754-760
15. Roila F, Ballatori E, Contu A. et al (1998) Optimal dose of intravenous (iv) dexamethasone (dex) in the prevention of cisplatin (CDDP)-induced acute emesis: a double-blind, randomized study. Proc Am Soc Clin Oncol 17:195
16. Sullivan JR, Leyden MJ (1983) Decreased cisplatin-induced nausea and vomiting with chronic alcohol ingestion (letter). N Engl J Med 309:796
17. Zook DJ, Yasko JM (1983) Psychologic factors: their effect on nausea and vomiting experienced by clients receiving chemotherapy. Oncol Nurs Forum 10:76-81